These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36872635)
1. Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single-country, multi-center, patient-reported outcome study. Kuo WL; Lin PH; Peng MT; Chu CH; Cho CW J Genet Couns; 2023 Aug; 32(4):788-797. PubMed ID: 36872635 [TBL] [Abstract][Full Text] [Related]
2. Uptake of genetic counseling and multi-gene panel testing among women in the Intermountain West with previous negative BRCA1 and BRCA2 results contacted for updated testing. Mooney R; Espinel W; Elrick A; Kehoe K; Kohlmann W; Kaphingst KA J Genet Couns; 2022 Apr; 31(2):470-478. PubMed ID: 34570943 [TBL] [Abstract][Full Text] [Related]
3. Genetic testing in Poland and Ukraine: should comprehensive germline testing of Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980 [TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil. Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148 [TBL] [Abstract][Full Text] [Related]
7. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland. McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O'Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ Fam Cancer; 2023 Apr; 22(2):135-149. PubMed ID: 36029389 [TBL] [Abstract][Full Text] [Related]
8. Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants. Machackova E; Claes K; Mikova M; Házová J; Sťahlová EH; Vasickova P; Trbusek M; Navrátilová M; Svoboda M; Foretová L Klin Onkol; 2019; 32(Supplementum2):51-71. PubMed ID: 31409081 [TBL] [Abstract][Full Text] [Related]
9. Chao A; Lin YH; Yang LY; Wu RC; Chang WY; Chang PY; Chang SC; Lin CY; Huang HJ; Lin CT; Chou HH; Huang KG; Kuo WL; Chang TC; Lai CH J Gynecol Oncol; 2020 May; 31(3):e24. PubMed ID: 31912679 [TBL] [Abstract][Full Text] [Related]
10. BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP Am J Med Genet A; 2005 Mar; 133A(2):165-9. PubMed ID: 15633195 [TBL] [Abstract][Full Text] [Related]
11. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey. Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574 [TBL] [Abstract][Full Text] [Related]
12. Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing? Infante M; Arranz-Ledo M; Lastra E; Abella LE; Ferreira R; Orozco M; Hernández L; Martínez N; Durán M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232793 [TBL] [Abstract][Full Text] [Related]
13. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families. Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278 [TBL] [Abstract][Full Text] [Related]
14. BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer. Nilsson MP; Törngren T; Henriksson K; Kristoffersson U; Kvist A; Silfverberg B; Borg Å; Loman N Breast Cancer Res Treat; 2018 Feb; 168(1):117-126. PubMed ID: 29164420 [TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families. Cherbal F; Bakour R; Adane S; Boualga K; Benais-Pont G; Maillet P Dis Markers; 2010; 28(6):377-84. PubMed ID: 20683152 [TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil. Mazzonetto P; Milanezi F; D'Andrea M; Martins S; Monfredini PM; Dos Santos Silva J; Perrone E; Villela D; Schnabel B; Nakano V; Palmero EI; Braggio E; Cavalcanti TL; Guida G; Migliavacca MP; Scapulatempo-Neto C; Zalcberg I Breast Cancer Res Treat; 2023 May; 199(1):127-136. PubMed ID: 36881271 [TBL] [Abstract][Full Text] [Related]
17. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of germline pathogenic Morgan RD; Burghel GJ; Flaum N; Bulman M; Clamp AR; Hasan J; Mitchell CL; Schlecht H; Woodward ER; Lallo FI; Crosbie EJ; Edmondson RJ; Wallace AJ; Jayson GC; Evans DGR J Med Genet; 2019 May; 56(5):301-307. PubMed ID: 30683677 [TBL] [Abstract][Full Text] [Related]
19. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341 [TBL] [Abstract][Full Text] [Related]
20. Attitude towards hereditary cancer risk management among women with cancer in Taiwan. Fang SY; Hsieh LL; Hung CF; Hung FH; Peng HP; Yang AS; Wang YA Support Care Cancer; 2022 Apr; 30(4):3625-3632. PubMed ID: 35028717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]